June 08, 2023
A Delaware bankruptcy judge Thursday approved generic-drug maker Lannett's prepackaged debt-swap Chapter 11 plan, overriding arguments that shareholders should have had a better opportunity to hang onto potential claims against the company and its executives.
June 02, 2023
Generic-drug maker Lannett told a Delaware bankruptcy judge Friday it has reached a deal with its unsecured creditors committee to end a clash that saw Lannett seek to dismiss the committee and the committee try to delay the hearing on Lannett's Chapter 11 plan.
May 04, 2023
Counsel for generic-drug maker Lannett told a Delaware bankruptcy judge on Thursday that the company is hoping to get approval for its Chapter 11 plan to cut $600 million in debt with an equity swap within a month.
May 03, 2023
Generic drugmaker Lannett filed for Chapter 11 protection in Delaware after striking an agreement with the bulk of its secured creditors and with a plan in hand for an equity swap it said will reduce its funded debt by nearly $600 million.